These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 38526051)

  • 21. Therapeutic Drug Monitoring of antibiotic and antifungical drugs in paediatric and newborn patients. Consensus Guidelines of the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Paediatric Infectious Diseases (SEIP).
    Luque S; Mendoza-Palomar N; Aguilera-Alonso D; Garrido B; Miarons M; Piqueras AI; Tévar E; Velasco-Arnaiz E; Fernàndez-Polo A
    An Pediatr (Engl Ed); 2024 Sep; 101(3):190-207. PubMed ID: 39278690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Translated article] Therapeutic Drug Monitoring of antibiotic and antifungical drugs in paediatric and newborn patients. Consensus Guidelines of the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Paediatric Infectious Diseases (SEIP).
    Luque S; Mendoza-Palomar N; Aguilera-Alonso D; Garrido B; Miarons M; Piqueras AI; Tévar E; Velasco-Arnaiz E; Fernàndez-Polo A
    Farm Hosp; 2024; 48(5):T234-T245. PubMed ID: 39271287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock.
    Varghese JM; Roberts JA; Lipman J
    Crit Care Clin; 2011 Jan; 27(1):19-34. PubMed ID: 21144984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients.
    Veiga RP; Paiva JA
    Crit Care; 2018 Sep; 22(1):233. PubMed ID: 30244674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applications of the pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents.
    Asín-Prieto E; Rodríguez-Gascón A; Isla A
    J Infect Chemother; 2015 May; 21(5):319-29. PubMed ID: 25737147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review.
    Phe K; Heil EL; Tam VH
    J Infect Dis; 2020 Jul; 222(Suppl 2):S132-S141. PubMed ID: 32691832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing.
    Natale S; Bradley J; Nguyen WH; Tran T; Ny P; La K; Vivian E; Le J
    Pharmacotherapy; 2017 Mar; 37(3):361-378. PubMed ID: 28079262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-infective Dosing for Obese Adult Patients: A Focus on Newer Drugs to Treat Methicillin-resistant Staphylococcus aureus Acute Bacterial Skin and Skin Structure Infections.
    Pai MP
    Clin Ther; 2016 Sep; 38(9):2032-44. PubMed ID: 27524636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.
    Heintz BH; Matzke GR; Dager WE
    Pharmacotherapy; 2009 May; 29(5):562-77. PubMed ID: 19397464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics.
    Bearden DT; Rodvold KA
    Clin Pharmacokinet; 2000 May; 38(5):415-26. PubMed ID: 10843460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of Commonly Used Antimicrobials in Critically Ill Pediatric Patients During Extracorporeal Membrane Oxygenation: A Systematic Review.
    Duceppe MA; Kanji S; Do AT; Ruo N; Cavayas YA; Albert M; Robert-Halabi M; Zavalkoff S; Benichou L; Samoukovic G; Williamson DR
    Paediatr Drugs; 2023 Sep; 25(5):515-535. PubMed ID: 37450191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic/Pharmacodynamic Target Attainment of Different Antifungal Agents in De-escalation Treatment in Critically Ill Patients: a Step toward Dose Optimization Using Monte Carlo Simulation.
    Xie J; Yang Q; Han X; Dong Y; Zhang T; Li Y; Ji M; Liu C; Cai Y; Wang Y
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0009922. PubMed ID: 35604209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review.
    Hodiamont CJ; van den Broek AK; de Vroom SL; Prins JM; Mathôt RAA; van Hest RM
    Clin Pharmacokinet; 2022 Aug; 61(8):1075-1094. PubMed ID: 35754071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic and pharmacodynamic issues for antimicrobial therapy in patients with cancer.
    Theuretzbacher U
    Clin Infect Dis; 2012 Jun; 54(12):1785-92. PubMed ID: 22437238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using pharmacokinetics and pharmacodynamics to optimise dosing of antifungal agents in critically ill patients: a systematic review.
    Sinnollareddy M; Peake SL; Roberts MS; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2012 Jan; 39(1):1-10. PubMed ID: 21925845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. External Validation of Obese/Critically Ill Vancomycin Population Pharmacokinetic Models in Critically Ill Patients Who Are Obese.
    Alsultan A; Dasuqi SA; Almohaizeie A; Aljutayli A; Aljamaan F; Omran RA; Alolayan A; Hamad MA; Alotaibi H; Altamimi S; Alghanem SS
    J Clin Pharmacol; 2024 Mar; 64(3):353-361. PubMed ID: 37862131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead.
    Velkov T; Abdul Rahim N; Zhou QT; Chan HK; Li J
    Adv Drug Deliv Rev; 2015 May; 85():65-82. PubMed ID: 25446140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimising antimicrobial therapy through the use of Bayesian dosing programs.
    Avent ML; Rogers BA
    Int J Clin Pharm; 2019 Oct; 41(5):1121-1130. PubMed ID: 31392582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation.
    Lyster H; Shekar K; Watt K; Reed A; Roberts JA; Abdul-Aziz MH
    Clin Pharmacokinet; 2023 Jul; 62(7):931-942. PubMed ID: 37300631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?
    Blot S; Lipman J; Roberts DM; Roberts JA
    Diagn Microbiol Infect Dis; 2014 May; 79(1):77-84. PubMed ID: 24602849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.